Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Medpace Holdings Inc (MEDP) – Medpace Holdings Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

MEDP trades at $415.27, down 0.93% on the day, with a bearish technical signal from moving averages. The company shows strong profitability with a 17.19% net margin and 77.25% ROE, and has beaten EPS estimates for three consecutive quarters. However, recent news is dominated by multiple class-action lawsuits alleging securities fraud, creating significant negative sentiment.
The outlook is mixed; strong fundamentals and a consensus price target of $446 suggest upside potential, but legal overhangs and bearish technicals present near-term risks. Investors must weigh robust earnings growth against the uncertainty from ongoing litigation.
Read full analysis

Key Stats

  • Market Cap
    $11.86B
  • Sector
    Technology
  • 3M Drawdown
    -25.55%
  • Enterprise Value
    $11.33B
  • Dividend Yield
    -
  • Typical Hold Time
    5 days
$415.27
52W Low: $293.03
22 May 2025
52W High: $620.59
21 Jan 2026

Medpace Holdings Inc (MEDP) is currently valued at a market capitalization of $11.86B, with an enterprise value of $11.33B. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $293.03 and a high of $620.59, highlighting its annual price range. Over the past three months, Medpace Holdings Inc has recorded a drawdown of -25.55%, reflecting recent price volatility. On average, investors hold Medpace Holdings Inc for approximately 5 days, indicating typical investor behavior on the platform.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.


Technical Indicators
|
|
|
Overall Summary
Bearish (18)Neutral (5)Bullish (4)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $11.86B
  • Sector
    Technology
  • 3M Drawdown
    -25.55%
  • Enterprise Value
    $11.33B
  • Dividend Yield
    -
  • Typical Hold Time
    5 days
$415.27
52W Low: $293.03
22 May 2025
52W High: $620.59
21 Jan 2026

Medpace Holdings Inc (MEDP) is currently valued at a market capitalization of $11.86B, with an enterprise value of $11.33B. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $293.03 and a high of $620.59, highlighting its annual price range. Over the past three months, Medpace Holdings Inc has recorded a drawdown of -25.55%, reflecting recent price volatility. On average, investors hold Medpace Holdings Inc for approximately 5 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!